Is age just a number? A population pharmacokinetic study of gemcitabine
ConclusionAge was not of influence on the pharmacokinetics of gemcitabine or its metabolite, dFdU. Age-related dose adjustments for gemcitabine based on pharmacokinetic considerations are not recommended.Trial registration numberNL39647.048.12, registered on May 3rd 2012.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Drugs & Pharmacology | Statistics | Study | Tics